Olmesartan Medoxomil Tablet, Film Coated
Product Images NDC 70518-4316

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil (NDC 70518-4316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Olmesartan Medoxomil 20 mg film-coated tablets packaging label. Contains 100 tablets. Label includes RX only designation, NDC number 70518-4316-00, manufacturing by ScieGen in Hauppauge, NY, and repackaging by RemedyRepack Inc., Indiana, PA. Storage instructions specify temperature controlled conditions with excursions permitted, and a QR code is present on the label.*
FDA Label Image

Structural Formula For Olmesartan Medoxomil (Olmesartan Medox Tabs Figure 1)

Structural Formula For Olmesartan Medoxomil (Olmesartan Medox Tabs Figure 1)
Chemical structure of olmesartan medoxomil, showing the molecular arrangement of atoms and bonds typical for this active ingredient in the 20 mg oral tablet form by Remedyrepack Inc.*
FDA Label Image

Olmesartan Medoxomil Dose Response: Placebo-adjusted Reduction In Blood Pressure (mm Hg) (Olmesartan Medox Tabs Figure 2)

Olmesartan Medoxomil Dose Response: Placebo-adjusted Reduction In Blood Pressure (mm Hg) (Olmesartan Medox Tabs Figure 2)
A dose-response graph depicting the placebo-adjusted reduction in systolic and diastolic blood pressure (mmHg) with increasing doses of olmesartan medoxomil (mg). The x-axis shows olmesartan medoxomil dose from 0 to 80 mg, and the y-axis shows blood pressure reduction. Data points indicate greater reductions in systolic pressure compared to diastolic as dose increases.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.